The Longitudinal Course of Schizophrenia Across the Lifespan: Clinical, Cognitive, and Neurobiological Aspects

Harvard Review of Psychiatry

Volumn 24, Issue 2, 2016, Pages 118-128

  Heilbronner, Urs ^a,c   Samara, Myrto ^d   Leucht, Stefan ^d   Falkai, Peter ^b   Schulze, Thomas G ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

diagnosis; imaging; longitudinal; neuropsychology; psychosis; schizophrenia

Indexed keywords

ADULTHOOD; AGE; BRAIN SIZE; CEREBROSPINAL FLUID; COGNITION; COGNITIVE DEFECT; DISEASE COURSE; EFFECT SIZE; FOLLOW UP; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; LIFESPAN; LONGITUDINAL STUDY; MEDLINE; MENTAL PATIENT; META ANALYSIS; NEGATIVE SYNDROME; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE; PHENOTYPE; POSITIVE SYNDROME; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SYMPTOMATOLOGY; WHITE MATTER; COGNITION DISORDERS; EXECUTIVE FUNCTION; FRONTAL LOBE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PSYCHOLOGY;

COGNITION; COGNITION DISORDERS; EXECUTIVE FUNCTION; FRONTAL LOBE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84962528018     PISSN: 10673229     EISSN: 14657309     Source Type: Journal    
DOI: 10.1097/HRP.0000000000000092     Document Type: Review

References (71)

1. Tandon R, Nasrallah HA, Keshavan MS,. "Just the facts": meandering in schizophrenias many forests. Schizophr Res 2011; 128: 5-6.
2. Kraepelin E,. Die Erscheinungsformen des Irreseins. Ztg Für Gesamte Neurol Psychiatr 1920; 62: 1-29.
3. Bleuler M,. A 23-year longitudinal study of 208 schizophrenics and impressions in regard to the nature of schizophrenia. J Psychiatr Res 1968; 6: 3-12.
4. Häfner H, an der Heiden W,. Course and outcome of schizophrenia. In: Hirsch SR, Weinberger DR,., eds. Schizophrenia. Oxford: Blackwell Science, 2007; 101-41.
5. Breier A, Schreiber JL, Dyer J, Pickar D,. National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. Arch Gen Psychiatry 1991; 48: 239-46.
6. Häfner H, an der Heiden W,. Methodological problems of longitudinal studies on schizophrenia. Fortschr Neurol Psychiatr 2000; 68: 193-205.
7. Arndt S, Andreasen NC, Flaum M, Miller D, Nopoulos P,. A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change. Arch Gen Psychiatry 1995; 52: 352-60.
8. Gur RE, Cowell P, Turetsky BI,. A follow-up magnetic resonance imaging study of schizophrenia. Relationship of neuroanatomical changes to clinical and neurobehavioral measures. Arch Gen Psychiatry 1998; 55: 145-52.
9. Reske M, Kellermann T, Habel U,. Stability of emotional dysfunctions? A long-term fMRI study in first-episode schizophrenia. J Psychiatr Res 2007; 41: 918-27.
10. Wang L, Mamah D, Harms MP,. Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia. Biol Psychiatry 2008; 64: 1060-8.
11. Maïza O, Mazoyer B, Hervé PY, Razafimandimby A, Dollfus S, Tzourio-Mazoyer N,. Reproducibility of fMRI activations during a story listening task in patients with schizophrenia. Schizophr Res 2011; 128: 98-101.
12. Cobia DJ, Smith MJ, Wang L, Csernansky JG,. Longitudinal progression of frontal and temporal lobe changes in schizophrenia. Schizophr Res 2012; 139: 1-6.
13. Möller H-J, Jäger M, Riedel M, Obermeier M, Strauss A, Bottlender R,. The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity. Eur Arch Psychiatry Clin Neurosci 2010; 260: 367-84.
14. Rosen C, Grossman LS, Harrow M, Bonner-Jackson A, Faull R,. Diagnostic and prognostic significance of Schneiderian first-rank symptoms: a 20-year longitudinal study of schizophrenia and bipolar disorder. Compr Psychiatry 2011; 52: 126-31.
15. Goghari VM, Harrow M, Grossman LS, Rosen C,. A 20-year multi-follow-up of hallucinations in schizophrenia, other psychotic, and mood disorders. Psychol Med 2012; 1: 1-10.
16. Harvey PD, Lombardi J, Leibman M,. Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: a follow-up study. Schizophr Res 1996; 22: 223-31.
17. McGurk SR, Moriarty PJ, Harvey PD, Parrella M, White L, Davis KL,. The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia. Schizophr Res 2000; 42: 47-55.
18. Spitzer RL, Endicott J, Robins E,. Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35: 773-82.
19. Kendler KS,. The super-normal control group in psychiatric genetics: possible artifactual evidence for coaggregation. Psychiatr Genet 1990; 1: 45-53.
20. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
21. Higgins JPT, Green S,., eds. Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Cochrane Collaboration, 2011.
22. Rund BR,. Distractibility and recall capability in schizophrenics. A 4 year longitudinal study of stability in cognitive performance. Schizophr Res 1989; 2: 265-75.
23. Friedman JI, Harvey PD, Coleman T,. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimers disease and normal aging. Am J Psychiatry 2001; 158: 1441-8.
24. Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV,. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001; 58: 24-32.
25. Albus M, Hubmann W, Scherer J,. A prospective 2-year follow-up study of neurocognitive functioning in patients with first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci 2002; 252: 262-7.
26. Brodaty H, Sachdev P, Koschera A, Monk Dorothy, Cullen B,. Long-term outcome of late-onset schizophrenia: 5-year follow-up study. Br J Psychiatry 2003; 183: 213-9.
27. Burdick KE, Goldberg JF, Harrow M, Faull RN, Malhotra AK,. Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia. J Nerv Ment Dis 2006; 194: 255-60.
28. Bonner-Jackson A, Grossman LS, Harrow M, Rosen Cherise,. Neurocognition in schizophrenia: a 20-year multi-follow-up of the course of processing speed and stored knowledge. Compr Psychiatry 2010; 51: 471-9.
29. Degreef G, Ashtari M, Wu HW, Borenstein M, Geisler S, Lieberman J,. Follow up MRI study in first episode schizophrenia. Schizophr Res 1991; 5: 204-6.
30. Davis KL, Buchsbaum MS, Shihabuddin L,. Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry 1998; 43: 783-93.
31. Mathalon DH, Sullivan EV, Lim KO, Pfefferbaum A,. Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 2001; 58: 148-57.
32. Puri BK, Hutton SB, Saeed N,. A serial longitudinal quantitative MRI study of cerebral changes in first-episode schizophrenia using image segmentation and subvoxel registration. Psychiatry Res 2001; 106: 141-50.
33. Ho B-C, Andreasen NC, Nopoulos P, Arndt Stephan, Magnotta V, Flaum M,. Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. Arch Gen Psychiatry 2003; 60: 585-94.
34. Kasai K, Shenton ME, Salisbury DF,. Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 2003; 60: 766-75.
35. Whitworth AB, Kemmler G, Honeder M,. Longitudinal volumetric MRI study in first-and multiple-episode male schizophrenia patients. Psychiatry Res 2005; 140: 225-37.
36. Price G, Cercignani M, Bagary MS,. A volumetric MRI and magnetization transfer imaging follow-up study of patients with first-episode schizophrenia. Schizophr Res 2006; 87: 100-8.
37. Whitford TJ, Grieve SM, Farrow TFD,. Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage 2006; 32: 511-9.
38. Nakamura M, Salisbury DF, Hirayasu Y,. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol Psychiatry 2007; 62: 773-83.
39. Brans RGH, van Haren NEM, van Baal GCM,. Longitudinal MRI study in schizophrenia patients and their healthy siblings. Br J Psychiatry 2008; 193: 422-3.
40. Rais M, Cahn W, Haren NV,. Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients. Am J Psychiatry 2008; 165: 490-6.
41. Sun D, Stuart GW, Jenkinson M,. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry 2009; 14: 976-86.
42. Yoshida T, McCarley RW, Nakamura M,. A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia. Schizophr Res 2009; 113: 84-94.
43. Koo M-S, Levitt JJ, Salisbury DF, Nakamura M, Shenton ME, McCarley RW,. A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch Gen Psychiatry 2008; 65: 746-60.
44. Trzesniak C, Schaufelberger MS, Duran FLS,. Longitudinal follow-up of cavum septum pellucidum and adhesio interthalamica alterations in first-episode psychosis: a population-based MRI study. Psychol Med 2012; 42: 1-12.
45. Palmer BW, Dawes SE, Heaton RK,. What do we know about neuropsychological aspects of schizophrenia? Neuropsychol Rev 2009; 19: 365-84.
46. Szöke A, Trandafir A, Dupont M-E, Méary Alexandre, Schürhoff F, Leboyer M,. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br J Psychiatry 2008; 192: 248-57.
47. Wölwer W, Brinkmeyer J, Riesbeck M,. Neuropsychological impairments predict the clinical course in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2008; 258: 28-34.
48. Mojtabai R, Bromet EJ, Harvey PD, Carlson GA, Craig TJ, Fennig S,. Neuropsychological differences between first-admission schizophrenia and psychotic affective disorders. Am J Psychiatry 2000; 157: 1453-60.
49. Royall DR, Lauterbach EC, Cummings JL,. Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 2002; 14: 377-405.
50. Baddeley AD,. Working memory. New York: Oxford University Press, 1986.
51. Norman D, Shallice T,. Attention to action. In: Davidson R, Schwartz G, Shapiro D,., eds. Consciousness and self-regulation. New York: Springer, 1986: 1-18.
52. Friedman NP, Miyake A, Corley RP, Young SE, Defries JC, Hewitt JK,. Not all executive functions are related to intelligence. Psychol Sci 2006; 17: 172-9.
53. Salthouse TA,. Relations between cognitive abilities and measures of executive functioning. Neuropsychology 2005; 19: 532-45.
54. Granholm E, Link P, Fish S, Kraemer H, Jeste D,. Age-related practice effects across longitudinal neuropsychological assessments in older people with schizophrenia. Neuropsychology 2010; 24: 616-24.
55. Shepherd AM, Laurens KR, Matheson SL, Carr VJ, Green MJ,. Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev 2012; 36: 1342-56.
56. Olabi B, Ellison-Wright I, McIntosh AM, Wood SJ, Bullmore E, Lawrie SM,. Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry 2011; 70: 88-96.
57. Théberge J, Williamson KE, Aoyama N,. Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia. Br J Psychiatry J Ment Sci 2007; 191: 325-34.
58. Jäncke L,. Methoden der Bildgebung in der Psychologie und den kognitiven Neurowissenschaften. Stuttgart, Germany: Kohlhammer, 2005.
59. Malaspina D, Owen MJ, Heckers S,. Schizoaffective disorder in the DSM-5. Schizophr Res 2013; 150: 21-5.
60. Cuthbert BN, Insel TR,. Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria project. Schizophr Bull 2010; 36: 1061-2.
61. Ho B-C, Andreasen NC, Ziebell S, Pierson R, Magnotta V,. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 2011; 68: 128-37.
62. Harrow M, Jobe TH, Faull RN,. Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study. Psychol Med 2014; 44: 3007-16.
63. Zipursky RB, Reilly TJ, Murray RM,. The myth of schizophrenia as a progressive brain disease. Schizophr Bull 2012; 39: 1363-72.
64. Kurtz MM,. Neurocognitive impairment across the lifespan in schizophrenia: an update. Schizophr Res 2005; 74: 15-26.
65. Schaie KW,. A general model for the study of developmental problems. Psychol Bull 1965; 64: 92-107.
66. Baltes PB,. Longitudinal and cross-sectional sequences in the study of age and generation effects. Hum Dev 1968; 11: 145-71.
67. Schaie KW, Baltes PB,. On sequential strategies in developmental research: description or explanation. Hum Dev 1975; 18: 384-90.
68. Schaie KW, Parham IA,. Cohort-sequential analyses of adult intellectual development. Dev Psychol 1977; 13: 649.
69. Weinberger DR,. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-9.
70. Bilder RM, Lipschutz-Broch L, Reiter G, Geisler SH, Mayerhoff DI, Lieberman JA,. Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration. Schizophr Bull 1992; 18: 437-48.
71. Kapur S, Phillips AG, Insel TR,. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry 2012; 17: 1174-9.